WO2024046764 - SELECTIVE MEDICAMENT DELIVERY ASSEMBLY WITH FLUIDIC ACTIVATION
National phase entry is expected:
Publication Number
WO/2024/046764
Publication Date
07.03.2024
International Application No.
PCT/EP2023/072541
International Filing Date
16.08.2023
Title **
[English]
SELECTIVE MEDICAMENT DELIVERY ASSEMBLY WITH FLUIDIC ACTIVATION
[French]
ENSEMBLE D'ADMINISTRATION SÉLECTIVE DE MÉDICAMENT À ACTIVATION FLUIDIQUE
Applicants **
SHL MEDICAL AG
Gubelstrasse 22, PO Box 7710
6302 Zug, CH
Inventors
COYNE III, Martin Michael
141 Hawkins Place #122
Boonton, 07005, US
CAIZZA, Richard James
100 Manhattan Avenue Apt 1709
Union City, 07087, US
Priority Data
63/402,547
31.08.2022
US
22199289.4
30.09.2022
EP
63/444,597
10.02.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1211 | |
| EPO | Filing, Examination | 4626 | |
| Japan | Filing | 596 | |
| South Korea | Filing | 640 | |
| USA | Filing, Examination | 2710 |
Total: 9783 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A sub-assembly (100) for a medicament delivery device, comprising: a housing (101); a closed chamber (108); a tubing set (102) transversally connected to the chamber, wherein the tubing set is arranged to provide one of a first medicament flow and a second medicament flow, a first fluid pressure is effectuated in the chamber when the first medicament is provided and a second fluid pressure having a different value from the first fluid pressure is effectuated when the second medicament is provided, thereby a fluid pressure change is effectuate due to a change between the provision of the first medicament and the second medicament; a shuttle (105) arranged in the chamber and connected to the tubing set, wherein the shuttle is configured to move transversally between a first position (1051) and a second position (1052) within the chamber when the fluid pressure change within the chamber exceeds a predetermined level.[French]
La présente invention concerne un sous-ensemble (100) pour un dispositif d'administration de médicament, comprenant : un boîtier (101) ; une chambre fermée (108) ; un ensemble tubulure (102) connecté transversalement à la chambre, l'ensemble tubulure étant agencé pour fournir l'un d'un premier flux de médicament et d'un second flux de médicament, une première pression de fluide étant effectuée dans la chambre lorsque le premier médicament est fourni et une seconde pression de fluide ayant une valeur différente de la première pression de fluide étant effectuée lorsque le second médicament est fourni, ainsi un changement de pression de fluide est effectué du fait d'un changement entre la fourniture du premier médicament et du second médicament ; une navette (105) agencée dans la chambre et connectée à l'ensemble tubulure, la navette étant configurée pour se déplacer transversalement entre une première position (1051) et une seconde position (1052) à l'intérieur de la chambre lorsque le changement de pression de fluide à l'intérieur de la chambre dépasse un niveau prédéterminé.